Recently, unique activation patterns in the MAPK pathway have also been described in plasmablastic lymphoma, distinct from those observed in DLBCL, and involving the overexpression of NTRK genes (NTRK1 and NTRK2) [35]. This evidence concerns the gene NTRK1 and diffuse large B-cell lymphoma.